December 4, 2023 U.S. Attorney’s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Big Sandy Regional Detention Center
Justice Department Secures Agreement from Pennsylvania Jail to Provide Medications for Opioid Use Disorder The Justice Department announced today that Allegheny County, Pennsylvania has agreed to offer treatment with any Food and Drug Administration (FDA)-approved medication for opioid use disorder (OUD) to all individuals booked into…
U.S. Attorney’s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Fayette County Detention Center
Former Nurse Sentenced to 18 Months in Federal Prison for Tampering with Morphine Medications at Moses Lake Clinic
Nearly 24,000 Pounds of Unused Medications Collected in Pacific Northwest During DEA Drug Take Back Day
DOJ and Skagit County health clinic resolve False Claims Act investigation over the use of imported birth control medications
U.S. Attorney Rollins Announces Correctional Facilities Statewide to Maintain All Medications for Opioid Use Disorder
Federal Civil and Criminal Investigations Result in Six Convictions and Recovery of Over $8.7 Million in Connection with Compounded Medications Formulated by DelCo Pharmacy
U.S. Attorney’s Office Settles Disability Discrimination Allegations with the Massachusetts Trial Court Concerning Access to Medications for Opioid Use Disorder
New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy
Atlanta pharmacy to pay $4.6 million to settle False Claims Act allegations regarding compound medications